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ABSTRACT
Endonuclease G (EndoG) is a nuclear-encoded endonuclease, mostly localised 
in mitochondria. In the nucleus EndoG participates in site-specific cleavage during 
replication stress and genome-wide DNA degradation during apoptosis. However, the 
impact of EndoG on mitochondrial DNA (mtDNA) metabolism is poorly understood. 
Here, we investigated whether EndoG is involved in the regulation of mtDNA replication 
and removal of aberrant copies. We applied the single-cell mitochondrial Transcription 
and Replication Imaging Protocol (mTRIP) and PCR-based strategies on human cells 
after knockdown/knockout and re-expression of EndoG. Our analysis revealed that 
EndoG stimulates both mtDNA replication initiation and mtDNA depletion, the two 
events being interlinked and dependent on EndoG’s nuclease activity. Stimulation of 
mtDNA replication by EndoG was independent of 7S DNA processing at the replication 
origin. Importantly, both mtDNA-directed activities of EndoG were promoted by 
oxidative stress. Inhibition of base excision repair (BER) that repairs oxidative stress-
induced DNA damage unveiled a pronounced effect of EndoG on mtDNA removal, 
reminiscent of recently discovered links between EndoG and BER in the nucleus. 
Altogether with the downstream effects on mitochondrial transcription, protein 
expression, redox status and morphology, this study demonstrates that removal 
of damaged mtDNA by EndoG and compensatory replication play a critical role in 
mitochondria homeostasis. 
INTRODUCTION
Mitochondria harbour their own small circular 
DNA (16569 bp in size in humans), which encodes 13 
proteins, essential for the functionality of the electron 
transport chain (ETC), 22 tRNAs as well as 2 ribosomal 
RNAs (Figure 1A). mtDNA molecules contain a non-
coding region (NCR), where the light and heavy strand 
promoters (LSP and HSP) as well as the origin of heavy 
strand replication (OH) are located [1, 2]. To date two 
prevalent models describe replication in mammalian 
mitochondria: First, the strand-displacement replication 
model, which was suggested in the 1970s and postulates 
that heavy-strand synthesis starts within the displacement-
loop (D-loop) near or at OH and proceeds unidirectionally 
until after two thirds the light-strand DNA synthesis 
is initiated at OL (origin of light strand replication) on 
the other strand [3]. According to this model mtDNA 
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replication results in single-stranded intermediates, which 
are coated and stabilised by the mitochondrial single-
stranded DNA binding protein (mtSSB). Second, the 
RITOLS (Ribonucleotide Incorporated ThroughOut the 
Lagging Strand) model also proceeds via such heavy-
strand intermediates, however, the light-strand becomes 
temporarily hybridised to RNA, which is subsequently 
removed prior DNA synthesis [4]. According to this last 
model, also-called the bootlace mechanism, this RNA 
is derived from processed transcripts, threaded onto the 
displaced light-strand template to aid protecting single-
stranded intermediates from damage and nucleolysis 
[5]. The occurrence of each of these mechanisms is 
still a matter of debate. Possibly different replication 
modes are utilised for specific requirements, such as 
under physiological conditions versus recovery after 
mtDNA depletion [6]. Both models include in a fraction 
of initiation events the production of a short fragment 
of DNA that terminates about 700 nt downstream of the 
replication origin OH, the 7S DNA, that remains associated 
with the replication structure forming a triple-stranded 
DNA. The role of 7S DNA is still unclear [7].
According to these specific requirements the 
mtDNA replication machinery is distinct from those 
in the nucleus. Mainly three key proteins, encoded by 
nuclear genes, form the mitochondrial replisome. The 
mtDNA polymerase γ (POLγ) [8], the replication helicase 
TWINKLE, which unwinds double stranded mtDNA in 5′ 
-> 3′ direction [9], and mtSSB, that may protect mtDNA 
during the replication process and additionally stimulates 
the activities of POLγ [10] and TWINKLE [9]. In humans 
mtDNA replication primers are formed via transcription 
from the LSP. The transition from transcription to 
replication has been mapped to the conserved sequence 
block (CSB) II region, which is located approximately 
100 nucleotides upstream of OH. It is still unclear which 
factors are involved in the termination of transcription in 
CSBII [1]. It has been claimed that primers are removed 
by ribonuclease H1 (RNASEH1) [11] and subsequently 
nascent DNA is processed from CSBII down to OH by 
the mitochondrial genome maintenance exonuclease-1 
(MGME1), possibly to ensure a proper ligation site by 
DNA ligase III after completion of replication of both ends 
of newly synthesised DNA [1].
In 1993, Côté and Ruiz-Carrillo [12] suggested 
that the major mitochondrial magnesium/manganese-
dependent nuclease, EndoG, is involved in the initiation 
of mtDNA replication by RNA primer maturation. In this 
report it was proposed to preferentially target the C/G-rich 
CSBII sequence, thereby acting as RNase H. However, 
this hypothesis was not pursued further. Moreover, two 
independent EndoG-depleted (EndoG-/-) mouse models did 
not show an effect on mtDNA copy number, structure or 
mutation rate [13, 14]. More recently McDermott Roe et 
al. [15] reported that EndoG regulates mitochondrial mass, 
function and reactive oxygen species (ROS) production in 
cardiac tissue of one of these EndoG-/- mice and modulates 
the expression of mitochondrial proteins. In the light 
of these observations, it is necessary to revisit EndoG’s 
role in mitochondrial biogenesis. EndoG is encoded by 
nuclear genes [16] and targeted to mitochondria as an 
inactive precursor protein by a mitochondrial targeting 
sequence [17]. Subsequently, this sequence is cleaved 
off, giving rise to the mature form of the nuclease 
(~29 kDa). EndoG is well-known to participate in nuclear 
genome degradation during programmed cell death 
[18, 19], but was recently discovered to also cleave the 
breakpoint cluster region in the Mixed-lineage leukemia 
(MLL) gene during replication stress [20]. EndoG is 
directly regulated by Estrogen-related receptor alpha 
(ERRα) and Peroxisome proliferator-activated receptor 
gamma coactivator 1α (PGC1α), which are known to be 
key regulators of mitochondria [15]. For a long time EndoG 
was thought to localise exclusively within the mitochondrial 
intermembrane space [21], but later on it was also found 
to be bound to the mitochondrial inner membrane [22]. Its 
proximity to the mitochondrial matrix, where mtDNA is 
located, and the ability to cleave RNA, DNA and hybrid 
molecules makes EndoG an excellent candidate to be 
involved in mtDNA replication and mtDNA metabolism 
[12, 16, 23–25]. This notion was supported by experimental 
evidence demonstrating direct interaction of EndoG with 
mtDNA, in a mitochondrial transcription factor A (TFAM)-
like fashion [15]. Interestingly, the expression of EndoG 
in different rat tissues seems to correlate with the levels 
of oxidative phosphorylation (OXPHOS) [26]. Moreover, 
nicks in one DNA strand or other types of DNA damage 
enhance the cleavage susceptibility of EndoG, suggesting 
a role in the removal of oxidatively damaged mtDNA 
molecules [26, 27]. 
Several evidences thus point to EndoG`s 
involvement in physiological processes acting on 
mtDNA, but the precise function of this protein is still 
unknown. Since qualitative or quantitative abnormalities 
of mtDNA are associated with several human disorders 
such as neuromuscular and neurodegenerative 
mitochondriopathies, diabetes, cardiovascular diseases, 
cancer and aging [28–33], a better understanding of 
factors involved in mtDNA maintenance is indispensable. 
Therefore, the main aim of this study is to investigate the 
specific role of EndoG in mtDNA replication and cleavage 
impacting on mitochondrial genome integrity.
RESULTS
EndoG promotes mtDNA replication initiation 
independently of 7S DNA production
In order to analyse a potential role of EndoG in 
mtDNA replication and transcription at the single-cell 
level, we used the established mTRIP imaging protocol 
[34–36]. The principle of mTRIP is a combination 
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of RNA and DNA fluorescence in situ hybridization 
(FISH), relying on the following probe design: the mREP 
probe is localised in the upstream neighbourhood of the 
main replication origin OH (between the two divergent 
promoters LSP and HSP) and recognises non-transcribed 
DNA that becomes accessible during initiation of 
mtDNA replication; this signal includes the production 
of extended mtDNA replication as well as abortive 7S 
structures. The mTRANS probe is a mix of three probes 
indicating mitochondrial transcription by the labelling of 
processed mitochondrial RNAs and unprocessed immature 
mitochondrial RNAs encoded at different positions within 
the mitochondrial genome. A schematic illustration of 
the human mitochondrial genome and the probes used 
in mTRIP are represented in Figure 1A. When applying 
mTRIP on HeLa cells after silencing EndoG with siRNA, 
we observed a significant reduction in the fluorescence 
signal indicating diminished initiation of mtDNA OH 
replication (21% mREP, p < 0.0001) and transcript levels 
(25% mTRANS, p < 0.0001) in comparison to control 
cells with nsRNA (Figure 1B–1D), without a decrease 
in mitochondrial content indicated by MitoTracker 
DR and citric acid synthase activity (Supplementary 
Figure 1A, 1B). Western blotting validated that 
siRNA efficiently reduced the protein level of EndoG 
(Figure 1E). Whole cell lysates were analysed, since 
during unperturbed growth the majority of EndoG 
is located in the mitochondria (Supplementary 
Figure 1C). Notably, when we generated HeLa clones 
stably expressing EndoG-specific small hairpin RNA 
(shRNA), we observed phenotypic differences between 
individual knockdown clones already during the 
earliest cell passages (data not shown). To avoid clonal 
heterogeneity, we therefore focused on functional analysis 
after transient knockdown. 
Previous work has revealed that after initiation 
at or near OH replication of the heavy strand commonly 
terminates approximately 700 nucleotides further 
downstream, giving rise to 7S DNA [7, 37]. When 7S 
DNA hybridises to the circular parental molecule, a 
characteristic triple-stranded D-loop structure is generated. 
Since an involvement of a protein binding to the termination 
associated sequences (TAS) region has been discussed in 
the context of 7S DNA formation [7], we examined whether 
EndoG is involved in this process. To this end we measured 
7S DNA and mtDNA content by quantitative polymerase 
chain reaction (qPCR) using forward primer A targeting 
the 7S template region and two reverse primers, one 
targeting newly synthesised 7S DNA (B1) and the other 
one detecting synthesis beyond 7S DNA (B2) [38]. Primer 
pair A/B1 amplifies both 7S DNA as well as longer mtDNA 
(7S + mtDNA), whereas A/B2 produces a PCR product 
exclusively from synthesis beyond 7S DNA (mtDNA, 
Figure 2A). DNA synthesis beyond 7S DNA (mtDNA) 
significantly decreased by 39% after silencing EndoG 
(p < 0.0001). Similarly, EndoG knockdown caused a 
decrease of both 7S DNA and beyond (7S + mtDNA) by 
28% (p = 0.0002) (Figure 2A lower panel). Accordingly, 
Figure 1: Assessment of EndoG’s function in initiation of mitochondrial OH replication and mitochondrial transcription. 
(A) Organization of the human mitochondrial genome. Recognition sites of mREP and mTRANS probes for FISH labelling with mTRIP are 
indicated with red and green boxes, respectively. HSP and LSP - heavy - and light-strand promoter, OH - origin of heavy strand replication, 
NCR - non-coding region (adopted from [7]). (B) Representative confocal microscopic images of HeLa cells stained with DAPI and 
MitoTracker DR (250-1000 nM, 1 h) and labelled with mREP and mTRANS probes 48 h after EndoG knockdown with siRNA. Scale bars 
= 10 µm. Fluorescence-based quantification of (C) mREP (initiation of mtDNA replication near OH) and (D) mTRANS (mitochondrial 
transcription); n = 196–218 cells from 2 independent experiments. Data are expressed as mean ± SEM (****P < 0.0001; non-parametric 
Mann-Whitney test for unpaired samples). (E) Western blot analysis to validate efficient knockdown of EndoG.
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Figure 2: Examination of a potential role of EndoG in 7S DNA production and regulation of transcription. HeLa cells 
were cultured in glucose medium and transfected with control nsRNA or siRNA targeting EndoG (siEndoG) and cultivated for 48 h. (A) 
Upper panel: schematic representation of the NCR including the D-loop. H - heavy strand, L - light strand, HSP and LSP - heavy - and 
light-strand promoter. CSB - conserved sequence block, TAS - termination associated sequences, OH - origin of heavy strand replication. 
Primer positions for qPCR indicated with black arrowheads (reference: NC_012920.1, Gene Bank). 7S DNA and mtDNA content was 
determined using the same forward primer A and two specific reverse B primers. Primer B1 is located within 7S DNA, whereas B2 binds 
more downstream beyond 7S DNA (adopted from [7]). Lower panel: qPCR on total genomic DNA; 12S mtDNA level indicated full-
length mtDNA content and the nuclear encoded 18S rRNA DNA level served as internal control for data normalisation. n = 8–12 from 3-4 
independent experiments; (B) RT‐qPCR analysis of mitochondrial genes, which are targets of mTRANS labelling; the nuclear encoded 
TBP gene served as internal control for data normalisation. n = 9 from 3 independent experiments; Data are expressed as mean ± SEM (ns, 
not significant; *P < 0.05; ****P < 0.0001; non-parametric Mann-Whitney test for unpaired samples).
Oncotarget18313www.oncotarget.com
it is unlikely that EndoG is specifically involved in the 
regulation of 7S DNA production. However, when we 
additionally quantified the mtDNA level via qPCR specific 
for 12S DNA, which is located in the terminal part of the 
heavy-strand replication, we did not observe significant 
differences after EndoG silencing (p = 0.1402; Figure 
2A lower panel). Consistent with this observation also 
mitochondrial mass, determined by MitoTracker DR 
staining, did not show any significant changes after EndoG 
knockdown under these conditions, i.e. in glucose medium 
(see above, Supplementary Figure 1A). Interestingly 
however, EndoG silencing induced morphological 
abnormalities of mitochondria as detectable via 
transmission electron microscopy (Supplementary Figure 
1D). In specific, we noticed mitochondrial fragmentation 
from elongated, contiguous assemblies into smaller, round 
and disconnected units, suggesting functional deficits and/or 
a modulation of the mitochondrial fusion/fission machinery. 
Alterations in the complexes of the respiration chain I, II, 
III and V after silencing EndoG could be excluded via 
immunoblotting of the corresponding nuclear-encoded 
OXPHOS proteins (Supplementary Figure 1E). 
In agreement with mTRANS data (detection of 
processed mitochondrial RNAs and unprocessed immature 
mitochondrial RNAs) we measured a significant reduction 
of the 16S cDNA level (38%, p < 0.0001), whereas 
smaller decreases in CoxII (20%, p = 0.2581) and ND6 
(20%, p = 0.0939) cDNA levels after EndoG knockdown 
did not reach statistical significance (Figure 2B).
Taken together, and in agreement with our mREP 
data, EndoG stimulates mtDNA replication initiation 
at OH, not limited to 7S DNA production, and also 
stimulates mitochondrial transcription, at least at the level 
of ribosomal RNA. However, these EndoG effects do not 
consistently entail an increase in the mitochondrial mass 
despite an impact on mitochondrial morphology.
The nuclease activity of EndoG is necessary for 
the regulation of replication initiation
To analyse whether the nuclease activity of EndoG 
is relevant for mtDNA replication, we expressed either 
a wild-type (WT) or a catalytically inactive form of 
EndoG (EndoG-H141A) after CRISPR/Cas9-mediated 
EndoG knockout in HAP1 cells. EndoG-WT expression 
resulted in a significant 1.1-fold mREP signal increase 
in comparison to control cells, transfected with an 
empty vector (p < 0.0001, Figure 3A). Conversely, in 
cells expressing the nuclease-deficient EndoG mutant 
the mREP signal remained unchanged. Similarly, cells 
expressing a DNA binding deficient EndoG mutant 
(EndoG-R133A-H141A-R184A-R188A/EndoG-∆-
binding) displayed values for the initiation of replication 
signal (mREP) comparable to EndoG deficient controls 
(Figure 3B). Comparable expression of EndoG-WT, 
the catalytically inactive EndoG-H141A or EndoG-∆-
binding mutant was verified by Western blot analyses 
(Figure 3C, 3D). These results suggest that the DNA 
binding and nuclease activity of EndoG are essential for 
the regulation of replication initiation.
EndoG is involved in mitochondrial genome 
cleavage
Mitochondrial DNA is heavily exposed to ROS 
due to its close proximity to the respiratory chain and 
is therefore highly susceptible to oxidative damage 
[39, 40]. Oxidative lesions in the nuclear and 
mitochondrial genome can be repaired by BER [41–43], 
but excessive or persistent damage is known to trigger 
mtDNA elimination through degradation [44, 45]. The 
enzymes involved in degradation of oxidatively damaged 
mtDNA in humans are still unknown. To examine a 
potential involvement of EndoG in mitochondrial genome 
degradation, we performed a previously established long-
range PCR amplifying the entire mitochondrial genome 
with two sets of primers [46]. The positions of Set1 and 
2 primers are shown in Figure 4A. The PCR product 
of Set1 displayed no difference in the band intensity 
of mtDNA after knockdown of EndoG in HeLa cells 
(Figure 4B). Conversely, the mtDNA content of Set2 
increased significantly by 28% after EndoG silencing 
(p = 0.0161), indicating EndoG-dependent mtDNA 
cleavage in control cells. 
To examine the importance of EndoG’s nuclease 
activity for the observed mtDNA removal, we analysed 
mtDNA amplification of Set2 after expression of EndoG-
WT versus catalytically inactive mutant EndoG-H141A 
in HAP1 EndoG knockout cells. Whereas EndoG-WT 
expressing cells showed a decrease of Set2 mtDNA 
compared to control cells (average 29%, p = 0.0313), this 
was not the case with cells expressing the catalytically 
inactive mutant EndoG-H141A, (p > 0.9999) (Figure 4C).
We conclude that EndoG is involved in 
mitochondrial genome cleavage between positions 6134 
and 15793 in a manner dependent on EndoG’s nuclease 
activity. Given that we found EndoG’s nuclease activity 
to be necessary for both the stimulation of replication 
initiation of mtDNA and for mtDNA cleavage, we next 
asked whether ROS induced oxidative damage may trigger 
these EndoG activities. 
ROS and oxidative lesions promote mtDNA 
cleavage by EndoG and replication initiation
Mammalian cells are able to shift their energy 
metabolism, depending on the available type of sugar. 
Cells grown in glucose medium produce adenosine 
triphosphate (ATP) by OXPHOS and by metabolising 
glucose via glycolysis. When glucose is replaced with 
galactose, cells rely more on OXPHOS, which is a 
major source of ROS, than on glycolysis  (Figure 5A) 
Oncotarget18314www.oncotarget.com
[47, 48]. We analysed the impact of the sugar metabolism 
and endogenous ROS levels on mtDNA replication. 
Replication initiation measured by mTRIP was 
significantly (1.3-fold) enhanced when cells were grown 
in galactose medium in comparison to cells grown in 
glucose medium (Figure 5B). This finding confirmed the 
notion that initiation of OH replication is influenced by the 
mitochondrial metabolism. To gain a better understanding 
whether the increased initiation of OH replication after 
EndoG knockdown is indeed ROS/reactive nitrogen 
Figure 3: Impact of EndoG’s nuclease and DNA binding activity for regulation of initiation of OH replication. Left panel: 
representative confocal microscopic images of HAP1 EndoG knockout cells transfected with empty control plasmid or a plasmid expressing 
EndoG-WT, (A) the catalytically inactive EndoG-H141A mutant or (B) the EndoG-∆binding mutant, cultivated for 48 h, subsequently 
stained with DAPI and labelled with mREP probes. Right panel: Fluorescence-based quantification of mREP labelling. (A) n = 358–
401 cells from 3 independent experiments for EndoG-WT versus EndoG-H141A expressing cells; (B) n = 299–336 from 2 independent 
experiments for EndoG-WT versus EndoG-∆binding mutant expressing cells showing an increase after EndoG-WT expression; Data are 
expressed as mean ± SEM (ns, not significant; **P < 0.01, ****P < 0.0001; non-parametric Mann-Whitney test for unpaired samples); Scale 
bars = 10 µm. (C, D) Western blot analysis to validate equivalent expression of the different EndoG variant proteins. Note that EndoG 
variants WT and H141A were expressed with Myc-DDK tag (C), whereas WT and ∆binding variants as HaloTag® fusion proteins (D), 
with theoretical molecular masses of 29 kDa and 62 kDa, respectively, for the leader peptide-free mitochondrial proteins. Residual EndoG 
carrying the leader peptides with a theoretical molecular mass of 34 kDa were detectable for the Myc-DDK tagged proteins (C).
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species (RNS)-dependent and potentially linked to ROS/
RNS induced damage, we treated HeLa cells with the ROS 
and RNS scavenger manganese(III) 5,10,15,20-tetrakis(4-
benzoic acid)porphyrin (MnTBAP) [49, 50]. Highly 
toxic RNS are produced from harmless nitric oxide (NO) 
in the presence of ROS, therefore we did not limit this 
investigation to ROS. While EndoG knockdown revealed 
a significant decrease in replication initiation in galactose 
medium, this effect was eliminated after treatment with 
MnTBAP (Figure 5C). Therefore, we concluded that 
EndoG’s function in replication initiation is at least in part 
dependent on ROS and/or RNS. 
Since earlier work in yeast suggested a role of 
the EndoG ortholog in processing oxidative damage in 
mtDNA [51], we analysed the effect of enforced oxidative 
stress on mtDNA cleavage by EndoG. To this end we 
treated HeLa cells with H2O2 and measured the level 
of Set2 mtDNA with and without EndoG knockdown. 
H2O2 treatment (50 µM for 5 h) decreased the amount of 
Set2 mtDNA by 24%, but this decrease was completely 
abrogated when EndoG was silenced (Figure 5D). Thus, 
EndoG knockdown stabilises, at least in part, Set2 
mtDNA, suggesting that EndoG cleaves mtDNA carrying 
oxidative lesions. To test the influence of BER (that 
Figure 4: EndoG’s role in mtDNA degradation. (A) Scheme of positions of primer pairs for long-range PCR Set1 and Set2, which 
cover the whole mitochondrial genome in two overlapping segments. Set1 amplifies a fragment of 10,033 bp and Set2 a fragment of 6,910 
bp (on a genome of 16,569 bp, NC_012920.1 GenBank). (B) Upper panel: representative image of agarose gel electrophoresis of long-
range PCR on total genomic DNA isolated from HeLa cells grown in glucose medium and transfected with control nsRNA or siEndoG 
and subsequent cultivation for 48 h. Lower panel: quantification of 10 kb Set1 (n = 5 independent experiments with Hela cells grown in 
glucose medium) and 7 kb Set2 (n = 12 of 6 independent experiments with Hela cells grown in glucose or galactose medium) mtDNA band 
intensities after long-range PCR. (C) Left panel: representative image of agarose gel electrophoresis of long-range PCR on total genomic 
DNA isolated from HAP1 EndoG knockout cells transfected with a control plasmid or a plasmid expressing EndoG-WT or the catalytically 
inactive EndoG-H141A mutant for 48 h. The framed images were derived from the same agarose gel, obtained with the same exposure time. 
Right panel: quantification of Set2 mtDNA band; n = 8 independent experiments showing an decrease after EndoG-WT expression. Data 
are expressed as mean ± SEM (ns, not significant; *P < 0.05; Wilcoxon matched-pairs signed rank test). 
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repairs oxidative damage) in this process, we inhibited 
the key apurinic/apyrimidinic endonuclease 1 (APE1) 
enzyme via APE1inhibitorIII (APE1inhIII) and observed 
stabilisation of Set2 mtDNA (a 1.8-fold higher signal) by 
EndoG knockdown (Supplementary Figure 2A).
Given that oxidative stress exacerbated EndoG-
mediated destabilisation of mtDNA, we wondered 
whether EndoG itself has an influence on cellular ROS 
or RNS levels. Therefore, we measured oxidation of 
2’, 7’- dichlorofluorescin diacetate (DCF-DA) by ROS 
and Dihydrorhodamine 123 (DHR123) by RNS using 
fluorescence microscopy. EndoG knockdown induced 
the cellular ROS signal by 1.5-fold (Supplementary 
Figure 2B) as well as the RNS signal by 2.6-fold 
(Supplementary Figure 2C). As ROS is prevalently 
generated by the ETC in mitochondria, we evaluated 
the mitochondrial function by high-resolution 
respirometry using the OROBOROS Oxygraph-2k. 
Neither LEAK (the coupling efficiency) nor routine 
respiration nor complex I nor complex II activity 
showed significant alterations after EndoG knockdown 
(Supplementary Figure 2D). However, EndoG silencing 
induced a significant 1.3-fold increase in the maximal 
mitochondrial respiration (ETS, Supplementary 
Figure 2D), which could explain elevated ROS. Moreover, 
high ROS may also generate elevated RNS levels, via 
oxidation of NO after EndoG knockdown. 
Taken together, our data are consistent with EndoG 
cleaving mtDNA carrying oxidative lesions and in turn 
modulating the nitroso-redox balance (RNS/ROS levels) 
in a negative feedback loop. 
Down-regulation of EndoG affects the expression 
of proteins involved in mtDNA replication
Our experiments demonstrated an involvement 
of EndoG in the removal of oxidatively damaged 
mtDNA. We speculated that this activity might lead to 
a compensatory induction of initiation of mtDNA OH 
replication and, consequently, also to mitochondrial 
transcription. Consequently, we assessed whether EndoG 
affects factors known to be either part of the mitochondrial 
replication machinery or involved in BER. Western blot 
analysis revealed that EndoG knockdown did not alter 
Figure 5: Impact of ROS-induced oxidative stress on EndoG’s function in initiation of mtDNA OH replication and 
mtDNA degradation. (A) Graphical representation of cellular energy metabolism pathways of mammalian cells. Left panel: Cells grown 
in glucose medium produce ATP by means of OXPHOS as well as by metabolising glucose via glycolysis. Right panel: Galactose medium 
channels cells towards glutamine metabolism and enhances the activity of OXPHOS for ATP production instead of using glycolysis, with 
the consequence of an increased ROS formation (adopted from [47]). (B) Fluorescence-based quantification of mREP labelling (initiation 
of mitochondrial OH replication) of HeLa cells grown in glucose or galactose medium for 72 h; n = 166–228 cells from 3 independent 
experiments. (C) Fluorescence-based quantification of mREP labelling of HeLa cells grown in galactose medium (72 h) and transfected 
with control nsRNA or siEndoG (48 h) and treated with either NaOH (ctrl.) or the ROS/RNS scavenger MnTBAP (100 µM) for 24 h; n = 
214–225 from 3 independent experiments. Data are expressed as mean ± SEM. (ns, not significant; ****P < 0.0001; non-parametric Mann-
Whitney test for unpaired samples). (D) Left panel: representative image of agarose gel electrophoresis of long-range PCR on total genomic 
DNA isolated from from HeLa cells grown in galactose medium (72 h) and treated with H2O (ctrl.) or 50 µM H2O2 for 5 h. Right panel: 
quantification of Set2 mtDNA band; n = 2 independent experiments; data are expressed as mean ± SD. 
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the level of POLγ in HeLa cells (Figure 6A). Conversely, 
quantitative immunofluorescence microscopy indicated 
a significant decline of the helicase TWINKLE after 
EndoG knockdown by 37% (Figure 6B, p < 0.0001). 
mtSSB, which is also involved in both replication and 
BER [10, 52], was significantly reduced by 14% (Figure 
6C, p = 0.0223). Moreover, EndoG knockdown did not 
significantly affect APE1 levels (Figure 6D, p = 0.9535). 
Figure 6: Impact of EndoG on expression of factors involved in mitochondrial genome replication, BER or fusion. 
HeLa cells were grown in galactose medium (72 h) and transfected with control nsRNA or siEndoG and cultivated for 48 h. (A) Left panel: 
representative image of Western blot analysis of POLγ expression; right panel: quantification of Western blot analysis. n = 4 independent 
experiments. (B–F) Representative immunofluorescence microscopic images (left panel) and fluorescence-based quantification (right 
panel) of protein levels of (B) TWINKLE n = 120, (C) mtSSB n = 110–127, (D) APE1 n = 157–171, (E) MFN2 n = 157–171 or (F) OPA1 
n = 103–141 cells from 2 independent experiments each. Data are expressed as mean ± SEM (ns, not significant; *P < 0.05; ****P < 0.0001; 
non-parametric Mann-Whitney test for unpaired samples); Scale bars = 10 µm. 
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Thus, the mitochondrial replication machinery appears 
affected by EndoG silencing, whereas this may not be the 
case for the BER machinery.
Our observation of the influence of EndoG 
on the mitochondrial morphology (Supplementary 
Figure 1C) prompted us to also examine proteins involved 
in the fusion of mitochondrial membranes. First, we 
showed significant 40% reduction (p < 0.0001) of outer 
membrane fusion protein Mitofusin-2 (MFN2) after 
EndoG knockdown (Figure 6E), which is consistent with a 
previous study in H9c2 cardiomyocytes [53]. Conversely, 
the signal of the inner membrane fusion protein Optic 
atrophy-1 (OPA1) increased by 1.9-fold (Figure 6F, 
p < 0.0001). These results suggest improper balance of the 
fusion proteins upon EndoG knockdown. 
DISCUSSION
In this study, we investigated whether EndoG 
is involved in mitochondrial genome replication and 
maintenance in analogy with recently discovered nuclear 
functions of EndoG during replication stress [20, 54]. Our 
results show that EndoG promotes cleavage of mtDNA 
in consequence of oxidative and nitrosative stress, in turn 
inducing compensatory mtDNA replication. 
Our initial finding of reduced replication initiation 
after EndoG knockdown was obtained by single-cell 
based mTRIP and confirmed by qPCR-based data. In this 
way, we substantiated an earlier proposal of a potential 
involvement of EndoG in the regulation of mtDNA 
replication [12]. In the literature mtDNA replication is 
reported to prematurely terminate at a high frequency 
resulting in the so-called 7S DNA molecule [7, 37]. 7S 
DNA forms a D-loop structure through hybridisation to 
the parental strand. The mechanism underlying D-loop 
formation may involve the TAS sequence at its 3´ 
boundary and a yet unknown TAS binding protein, which 
remains to be clarified [55, 56]. However, our qPCR data 
indicate that EndoG is not the sought-after candidate, as 
it did not differentially alter 7S DNA levels compared 
with longer versions of newly synthesised mtDNA. In this 
way a specific influence of EndoG on mtDNA replication 
via interfering with D-loop formation could likely be 
excluded. 
We noticed that EndoG’s role in the regulation 
of replication is dependent on its DNA binding and 
in particular its nuclease activity, since expression of 
corresponding deficiency mutant proteins did not stimulate 
mtDNA replication initiation. Moreover, our data indicate 
that EndoG mediates cleavage of mtDNA between 
positions 6134 and 15793 (Set2), possibly in the NCR (see 
below). This cleavage reaction was again dependent on 
EndoG’s nuclease activity, suggesting cleavage of mtDNA 
by EndoG itself. Remarkably, EndoG-mediated cleavage 
of mtDNA was particularly pronounced in the presence of 
ROS or unrepaired base damage. Upregulation of mtDNA 
replication has previously been considered to represent 
a compensatory mechanism to cope with oxidatively 
damaged mtDNA [57, 58]. Interestingly, oxidative stress 
has been found to specifically affect the NCR region in 
HeLa cell mitochondria [59]. This region is enriched 
with guanine, which is a preferred target of oxidation, 
resulting in 8-oxo-G. We propose that EndoG´s role in 
upregulating mtDNA replication is an indirect outcome of 
its involvement in mtDNA degradation.
Our results are in agreement with work by 
Shokolenko et al. [45] revealing a decrease of mtDNA 
content after targeted accumulation of BER intermediates 
like apurinic/apyrimidinic (AP) sites in mtDNA. The 
authors suggested that while moderate oxidative mtDNA 
damage can be repaired by BER in mitochondria, 
mtDNA with more pronounced damage or excess repair 
intermediates will be degraded [45]. Here we demonstrate 
that EndoG is involved in this process of degradation, 
since in the absence of EndoG the cleavage reaction 
is diminished, which is particularly noticeable upon 
ROS exposure or APE1 inhibition. The fact that only a 
portion of mtDNA molecules are cleaved and degraded, 
as oxidative damage is primarily repaired by BER, can 
explain why, under unperturbed conditions, we observe 
only small changes in mtDNA levels as a function of 
EndoG. We therefore propose that EndoG is responsible 
for the cleavage reaction in severely oxidatively damaged 
mtDNA molecules or upon accumulation of the damage 
and BER intermediates. Conversely, none of the known 
mitochondrial nucleases, including EndoG, seem to be 
involved in massive mtDNA degradation, when DNA 
double strand breaks (DSBs) are introduced through 
expression of mitochondrially targeted restriction 
endonucleases [60]. 
Interestingly in 2014, Robertson et al. [61] 
demonstrated that EndoG preferentially cleaves double-
stranded DNA with 5-hydroxymethylcytosine (5hmC) 
modifications of non C-phosphate-G (CpG) sites and 
thereby induces DSBs. 5hmC is produced by oxidative 
demethylation of 5-methylcytosine (5mC) catalysed by 
the three ten-eleven-translocation (Tet) enzymes (Tet1, 2 
and 3) [62]. These modified cytosines are considered to 
some extent an epigenetic mark, involved in the regulation 
of gene expression of nuclear genes in the CpG context 
[63–67]. 5hmC was also found to colocalise with the 
DNA damage markers γH2AX and p53-binding protein 
1 (53BP1) in cells undergoing replication stress [68]. 
Recently, evidence was provided for the existence of 
5mC as well as 5hmC also in mtDNA [69], but the role of 
5hmC, in both the mitochondria and the nucleus, is not yet 
fully understood [65, 70, 71]. 
In this context it is of interest that we recently 
discovered that during replication stress EndoG cleaves 
genomic DNA in the nucleus in a concerted action with 
activation-induced cytidine deaminase (AID) and the 
BER machinery [54]. Both AID and BER are known 
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to be involved in the active demethylation process 
[71, 72]. Moreover, Zhang et al. [73] found that Tet2 
converts 5mC to 5hmC during oxidative stress such 
as after H2O2 treatment, thereby triggering DNA 
demethylation. Given that oxidative stress activates 
Tet proteins [74] and knowing that EndoG cleaves 
5hmC [61] in combination with our data indicating that 
EndoG-mediated cleavage of mtDNA is enhanced by 
oxidative stress, it is conceivable that Tet-dependent 
5mC to 5hmC conversion triggers cleavage by EndoG. 
Thus, 5hmC may label mtDNA damage sites for EndoG-
mediated cleavage, which is particularly relevant when 
oxidative damage as well as 5hmC cannot be efficiently 
corrected by BER and therefore need to be eliminated by 
degradation. We observed EndoG-dependent cleavage 
also when blocking the BER enzyme APE1, so that it 
is unlikely that the nucleases acting further downstream 
in BER, namely DNA replication helicase/nuclease 2 
(DNA2), Flap endonuclease 1 (FEN1), Exonuclease G 
(ExoG) and MGME1 play a major role in this process. 
Ultimately the linearised damaged mtDNA molecules are 
most likely degraded, as mitochondria lack efficient DSB 
repair mechanisms [60]. In the nucleus EndoG-mediated 
cleavage activates DSB repair mechanisms instead of 
DNA degradation [20, 61, 75]. 
As outlined above our work reveals that mtDNA 
cleavage by EndoG is connected to increased replication 
initiation. Our experiments also provide evidence that ROS 
production stimulates replication initiation. Here, we used 
HeLa cervix cancer cells, which are known to shift to aerobic 
glycolysis for ATP production rather than OXPHOS (known 
as Warburg effect) [76–78]. By using galactose medium we 
could force cells to increase their OXPHOS activity [79] 
and thereby also ROS production, since it is known that the 
ETC is a major endogenous source of ROS [48, 80]. With 
galactose medium we saw enhanced replication initiation 
compared to glucose medium. Moreover, EndoG’s impact 
on replication initiation was abolished in the presence of the 
ROS and RNS scavenger MnTBAP. Consistent with our 
hypothesis of compensatory mtDNA replication after 5hmC-
mediated EndoG cleavage of oxidatively damaged mtDNA, 
work by Kowluru and Shan [81] revealed that MnTBAP 
antagonises hydroxymethylation as well as Tet2 binding 
to DNA. Compensatory replication may serve to balance 
the loss of mtDNA and concomitantly promote passive 
replication-dependent demethylation of mtDNA [82]. 
According to our protein expression data, two components 
of the mtDNA replication machinery, the nuclear-coded 
TWINKLE and mtSSB, are good candidates to mediate 
replication stimulation by EndoG.
While we observed downregulation of newly 
started heavy strand synthesis at OH in the absence of 
EndoG, we did not observe significant alterations in 12S 
mtDNA levels. This apparent lack of correlation can be 
explained by the fact that 12S mtDNA is replicated late. 
It is possible that in the presence of EndoG, the number 
of initial, abortive molecules is larger than in the absence 
of the nuclease. This process could be linked to EndoG-
dependent regulation of mtDNA content. Additionally, 
12S mtDNA is part of Set2 targeted by EndoG-dependent 
degradation. In the absence of EndoG, reduced degradation 
may neutralise the effect of reduced synthesis resulting in 
apparently unaltered 12S mtDNA levels. Along this line, 
loss of mtDNA by EndoG might not be detectable in Set1 
as it is synthesised early during compensatory mtDNA 
replication. A possible explanation for the fact that Set2 
is preferentially removed by EndoG is that Set2 covers 
the mitochondrial NCR and the D-loop, i.e. hot spots of 
oxidative damage accumulation within mtDNA [83]. In 
this way especially Set2 might be a target for EndoG’s 
cleavage of oxidatively damaged DNA. Noteworthy, 
5hmC is enriched particularly in NCR mtDNA adjacent to 
7S DNA [84], including the CSBII region, which is known 
to be preferentially attacked by EndoG [23].
While we carved out that EndoG acts downstream of 
oxidative stress, we also noticed that EndoG knockdown 
induces maximal mitochondrial respiration and ROS/RNS 
production. In the light of EndoG´s role in the removal 
of oxidatively damaged mtDNA the latter observation is 
in line with published work indicating that unrepaired, 
persistent single-strand breaks (SSBs) and mutations in 
mtDNA lead to an increase in ROS formation [85, 86]. 
In contrast to earlier findings, here under conditions 
of transient EndoG knockdown, we did not detect 
OXPHOS impairment or changes in respiration complex 
components, for which prolonged EndoG depletion 
might be necessary [44]. However, mtDNA depletion, 
compensatory replication and elevated mitochondrial 
respiration after EndoG knockdown were accompanied 
by morphological changes of mitochondria. We noticed 
fragmentation of elongated, contiguous mitochondrial 
assemblies into smaller, round and disconnected units. 
This observation can on the one hand be explained by 
the fact that upon activation of OXPHOS, mitochondria 
change from the so-called “orthodox” to the “condensed” 
morphology, which is also accompanied with cristae 
remodelling [87, 88]. In the absence of EndoG, increased 
fission could further serve to isolate most severely 
damaged mitochondria and direct them to degradation by 
selective mitophagy [89, 90]. At first sight paradoxically, 
we observed opposite effects of EndoG knockdown 
on MFN2 and OPA1 levels, even though both proteins 
are involved in mitochondrial fusion. However, MFN2 
controls the fusion of the outer mitochondrial membrane, 
whereas OPA1 is needed for inner mitochondrial 
membrane fusion and independently plays a role in cristae 
remodelling [91]. Thereby OPA1 is able to modulate the 
stability of respiratory chain supercomplexes (RCS) and 
mitochondrial respiratory efficiency [92]. The imbalance 
between the two fusion factors may account for the altered 
morphology of mitochondria upon EndoG knockdown and 
elevated OPA1 additionally to mitochondrial respiration. 
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CONCLUSIONS
In summary, EndoG is a key regulator of the 
mtDNA damage response and in this way a critical factor 
for mitochondrial genome maintenance. Our data provide 
evidence that EndoG cleaves mtDNA when oxidative 
lesions cannot be efficiently repaired. The resulting 
depletion of mtDNA results in compensatory mtDNA 
replication via expression of proteins involved in mtDNA 
replication, such as TWINKLE and mtSSB (Figure 7). We 
hypothesise that this cleavage reaction may be initiated 
by demethylation processes at non-CpG sites, providing a 
potential biological role for the yet unknown function of 
5hmC accumulation in mtDNA. Since, changes in 5hmC 
mtDNA methylation are associated with a wide range of 
pathological conditions such as cancer, neurodegeneration 
and aging [65, 93], our observations broaden the current 
understanding of the development of these diseases and 
highlight EndoG as a potential target for future therapies. 
MATERIALS AND METHODS
Cell culture
Human HeLa cells (provided by Heinrich-Pette-
Institute, Hamburg, Germany) were propagated in DMEM 
medium (high glucose, 4mM L-glutamine, Gibco), 
supplemented with 10% foetal bovine serum (FBS) 
(Biochrom) and 2 mM L-glutamine (Gibco). Seventy-two 
hours before experiments HeLa cells were grown either 
in glucose or galactose medium as indicated. Galactose 
medium was composed of DMEM (without glucose, 
glutamine and phenol red), supplemented with 10% FBS, 
50 mM galactose and 4 mM L-glutamine. HAP1 cells 
Figure 7: Proposed model of EndoG-mediated induction of mtDNA OH replication initiation. Elevated ROS levels, which 
mainly originate from the mitochondrial ETC and are supplied e.g. by galactose metabolism, cause oxidative damage to mtDNA. In 
case this damage is not repaired by BER, EndoG might perform a cleavage reaction. The resulting depletion of mtDNA possibly leads to 
compensatorily increased OH replication initiation and downstream mitochondrial activities such as transcription.
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(Horizon Genomics, Vienna, Austria) were cultured in 
IMDM medium (Gibco), supplemented with 10% FBS. 
HAP1 is a near-haploid human cell line with fibroblast-
like morphology, which was derived from the male 
chronic myelogenous leukemia (CML) cell line KBM-7 
through cellular reprogramming [94]. All cells were grown 
at 37°C and 5% CO2.
Plasmids and small interfering RNA (siRNA)
Plasmids for expression of EndoG-WT and for 
EndoG-H141A were purchased from OriGene (pCMV6-
Entry Vector, RC205089). The EndoG-∆-binding (EndoG-
R133A-H141A-R184A-R188A) plasmid, which is 
based on the pLV-tetO-Oct4 plasmid (Addgene, 19766), 
was provided by J. Christof M. Gebhardt, Institute of 
Biophysics, Ulm University, Germany. Oct4 was replaced 
by the EndoG-WT or the mutated EndoG-∆-binding 
sequence (3050–4852 nucleotides including a HALO-
Tag®). pcDNA3.1 (Invitrogen) served as negative control. 
FlexiTube Gene-Solution GS2021 (Qiagen), which 
consists of a pool of four distinct siRNA, was used to 
transiently silence EndoG. Non-silencing RNA (nsRNA) 
(Qiagen, 1022076) served as negative control.
Transfection and treatments
Different plasmids were transiently transfected 
into HAP1 cells by lipofection, using FuGENE® HD 
Transfection Reagent (Promega). For siRNA-mediated 
EndoG knockdown in HeLa cells, HiPerFect® Transfection 
Reagent (Qiagen) was utilised. Medium was changed 
24 h after transfection and in case of ROS/RNS scavenger 
exposure cells were directly treated with 100 µM 
MnTBAP (Merck Millipore) or with the solvent NaOH 
(Fluka) for 24 h. For induction of oxidative stress 43 h 
post-transfection cells were exposed to 50 µM H2O2 
(Fischar) versus H2O (Braun) for 5 h.
Western blot
For preparation of HeLa and HAP1 lysates cell 
pellets were incubated in lysis buffer (50 mM Tris, pH 7.4; 
150 mM NaCl; 2 mM EGTA; 2 mM EDTA; 25 mM NaF; 
25 mM β-glycerophosphate; 0.1 mM NaV; 0.2% Triton 
X-100, 0.3% Nonidet P40), supplemented with protease 
inhibitor cocktail tablets (Roche). Protein concentrations 
were determined by means of the Pierce™ BCA Protein 
Assay Kit (Thermo Scientific). Afterwards 60 µg of 
protein were electrophoretically separated on 8–12% 
SDS-PAGE gels and blotted onto Hybond™-P 0.45 
PVDF (GE Healthcare) membranes. Immunodetection 
was performed using mouse-anti-human DNA POLγ 
(Santa Cruz, sc-390634 [95]) and EndoG (Santa Cruz, 
sc-365359 [20]) primary antibodies. Mouse-anti-human 
α-tubulin (Abcam, ab7291 [96]) and Glyceraldehyde-3-
phosphate-dehydrogenase (GAPDH, Abcam, ab9484 [97]) 
served as loading controls. Horseradish peroxidase (HRP)-
conjugated goat-anti-mouse (Rockland) was utilised as 
secondary antibody. The peroxidase activity was visualised 
by Clarity™ Western ECL Substrate (Bio-Rad) and 
images were recorded with ChemiDoc™ MP (Bio-Rad). 
Quantification of band intensities was performed using 
Image Lab 4.1 (Bio-Rad). Each value of band intensity 
was corrected with the value of the corresponding loading 
control (α-tubulin or GAPDH).
Immunofluorescence staining 
HeLa cells were cultured on glass slides (12 mm, 
VWR), fixed with 3.7% Formaldehyde (AppliChem 
Panreac ITW companies), permeabilised with 0.5% 
Triton X-100 (Sigma-Aldrich), washed shortly with 
0.05% Tween-20 (Merck) and blocked with 5% goat 
serum (Sigma-Aldrich) to avoid unspecific binding. 
For immunostaining slides were incubated for 1 h with 
the following primary antibodies (all from Santa Cruz): 
rabbit-anti-human mtSSB (sc-67101 [98]), TWINKLE 
(sc-134915 [99]) and APE1 (sc-334 [54]) as well as 
mouse-anti-human MFN2 (sc-100560 [100]) and OPA1 
(sc-393296 [101]). Alexa Fluor 555 anti-mouse, Alexa 
Fluor 555 anti-rabbit and Alexa Fluor 488 anti-rabbit 
(all from Invitrogen) were used as secondary antibodies. 
HeLa cells were mounted with Vectashield® containing 
4′,6-Diamidin-2-phenylindol (DAPI, Vector laboratories) 
to stain the nuclei and imaged using a Keyence BZ-
9000 microscope (Keyence Germany). The fluorescence 
intensity was analysed using the ImageJ 1.46/1.51 
software (National Institutes of Health). 
Total genomic DNA extraction
Total genomic DNA was either extracted using 
the QIAamp® DNA Mini Kit (Qiagen) or by classical 
isopropanol precipitation as follows: the cell pellet was 
incubated with 200 µl lysis buffer (0.2 mg/ml Proteinase 
K, 0.2% SDS, 5 mM EDTA in DPBS) for 3 h at 50°C. 
Afterwards 20 µl of 3M sodium acetate pH 5.2 and 300 µl 
of isopropanol (VWR Chemicals) were added to the 
lysates followed by incubation for 20min at -20°C and 
centrifugation (13000xg) for 30min at 4°C. Pellets 
were washed twice in 70% Ethanol (Honeywell) and 
resuspended in H2O (Braun). The total genomic DNA was 
quantified using NanoDrop 2000 Spectrometer (Thermo 
Scientific).
Long-range PCR
In order to amplify the complete mitochondrial 
genome in two overlapping segments (Set1 and Set2), 
a special long-range PCR was performed [46]. 20–70ng 
of total genomic DNA were applied to the PCR reaction 
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with LA Taq® DNA Polymerase (TaKaRa). Primer 
sequences are described in Supplementary Table 1. 27–38 
cycles were run at 94°C 1min, 94°C 30sec, 56°C 45sec, 
68°C 11min, 72°C 10min for denaturing, annealing and 
elongation. PCR products were loaded on 0.5–0.8% 
agarose gels and imaged by ChemiDoc™ MP (Bio-Rad). 
Band intensity was quantified using the Image Lab™ 
(Bio-Rad) software or ImageJ 1.46 (National Institutes of 
Health).
Probe labelling, denaturation and mTRIP 
imaging protocol
mTRIP was performed as previously described 
[34–36]. Briefly, mREP (marker of mitochondrial 
initiation of replication) and mTRANS (markers of 
mitochondrial transcripts) probes were amplified by PCR 
using 20ng of total genomic DNA. Primer sequences are 
represented in Supplementary Table 1. Cells were plated 
on slides, hybridised with mREP or mTRANS probes, 
washed with saline-sodium citrate (SSC), subsequently 
stained with Hoechst for 1 h or DAPI for 5min and washed 
with Dulbecco’s phosphate-buffered saline (DPBS). 
Slides were mounted with 50% glycerol (Roth) in DPBS 
and imaged using either a LSM710 or a Zeiss Axiovert 
200M confocal microscope. The fluorescence intensity 
was analysed with the ImageJ 1.34/1.46/1.51 software 
(National Institutes of Health).
MitoTracker staining
Mitochondria were stained with 250–1000 nM 
MitoTracker® Deep Red FM (MitoTracker DR, Life 
Technologies) at 37°C for 45 min –1 h and washed 
with medium and DPBS. Subsequently, cells were fixed 
with 2% Paraformaldehyde (PFA, Electron Microscopy 
Sciences), washed with DPBS and nuclei stained with 
1 µg/ml DAPI (Sigma) for 5 min. After additional washing 
steps, slides were mounted with 50% glycerol (Roth)/ 
DPBS. Images were taken using a LSM710 confocal 
microscope.
Reverse transcription quantitative polymerase 
chain reaction (RT-qPCR) and qPCR
For RT-qPCR total mRNA was isolated from 
HeLa cells using the RNeasy® Mini Kit, including 
DNase treatment, following reverse-transcription with 
QuantiTect® Reverse Transcription Kit (all from Qiagen).
Total genomic DNA was employed for qPCR. The 
primers used (from Thermo Fisher and Biomers) are listed 
in Supplementary Table 1. Both RT-qPCR and qPCR were 
performed using KAPA SYBR® FAST qPCR Kit (peqlab/ 
VWR) on a Viia7 RUO thermocycler (Applied Biosystems 
Life Technologies). Data was analysed by Viia7 RUO 
software version 1.2.1. mRNA expression of target genes 
was calculated with the 2−ΔΔCt method, whereby TATA 
box binding protein (TBP) transcript levels served as an 
internal control. For 7S and mtDNA analysis by qPCR the 
2ΔCt method was used and 18S rRNA served as internal 
control. 
Statistical analysis
Graphical presentation of data was performed by 
means of GraphPad Prism 7.03 (GraphPad Software 
Inc.) and statistical significance was analysed by using 
non-parametric Mann-Whitney test for unpaired samples 
or Wilcoxon matched-pairs signed rank test for related 
samples. *P < 0.05; **P < 0.01; ****P < 0.0001.
Abbreviations
53BP1 - p53-binding protein 1, AP - apurinic/
apyrimidinic, APE1 - apurinic/apyrimidinic endonuclease 
1, APE1inhIII - APE1inhibitorIII, ATP - adenosine 
triphosphate, BER - base excision repair, C - complex, CML 
- chronic myelogenous leukemia, CSB - conserved sequence 
block, DCF - 2’, 7’- Dichlorofluorescein, DCF-DA - 2’, 7’- 
dichlorofluorescin diacetate, DHR123 - Dihydrorhodamine 
123, D-loop - displacement-loop, DNA2 - DNA replication 
helicase/nuclease 2, DPBS - Dulbecco’s phosphate-
buffered saline, DTNB - 5, 5´dithiobis-2-nitrobenzoic acid, 
EndoG - Endonuclease G, ETC - electron transport chain, 
ERRα - Estrogen-related receptor alpha, ETS - maximal 
mitochondrial respiration, ExoG - Exonuclease G, FCCP 
- carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone, 
FEN1 - Flap endonuclease 1, FISH - fluorescence in situ 
hybridization, Fwd - forward primer, H - heavy strand, 
GAPDH - Glyceraldehyde-3-phosphate-dehydrogenase, 
5hmC - 5-hydroxymethylcytosine, HSP - heavy strand 
promoter, HRP - Horseradish peroxidase, L - light strand, 
LSP - light  strand promoter, MFN2 - Mitofusin-2, 
DSBs - double strand breaks, MGME1 - mitochondrial 
genome maintenance exonuclease-1, MitoTracker DR – 
MitoTracker Deep Red, MLL - Mixed-lineage leukemia, 
mtDNA -  mitochondrial DNA, mTRIP - mitochondrial 
Transcription and Replication Imaging Protocol, MnTBAP 
- manganese(III) 5,10,15,20-tetrakis(4-benzoic acid)
porphyrin, mtSSB - mitochondrial single-stranded DNA 
binding protein, NCR - non-coding region, NO - nitric 
oxide, ns - not significant, OH - origin of heavy strand 
replication, OL - origin of light strand replication, OPA1 - 
Optic atrophy-1, OXPHOS - oxidative phosphorylation, 
PFA - Paraformaldehyde, PGC1α - Peroxisome proliferator-
activated receptor gamma coactivator 1α, POLγ - polymerase 
γ, qPCR - quantitative polymerase chain reaction, RCS - 
respiratory chain supercomplexes, RNS - reactive nitrogen 
species, rev - reward primer, RITOLS - Ribonucleotide 
Incorporated ThroughOut the Lagging Strand, RNASEH1 
- ribonuclease H1, ROS - reactive oxygen species, RT-
qPCR - Reverse transcription quantitative polymerase 
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chain reaction, shRNA - small hairpin RNA, siRNA - small 
interfering RNA, SSB - single-strand break, SSC - saline-
sodium citrate, TAS - termination associated sequences, TBP 
- TATA box binding protein, Tet - ten-eleven-translocation, 
TFAM - mitochondrial transcription factor A, TNB - 2-nitro-
5-benzoic acid, WT - wild-type.
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